Healthcare Sector Stocks
The Healthcare sector has a total of 1062 stocks, with a combined market cap of $8.24 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.04.
Market Cap
8.24T
Revenue
4.59T
Profits
200.68B
PE Ratio
41.04
Profit Margin
4.37%
Dividend Yield
0.44%
1061 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 910.83B | 3.37% | 3,795,468 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 553.66B | 0.47% | 9,675,471 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 377.67B | 2.08% | 7,220,277 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 353.49B | -0.48% | 5,016,808 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 288.35B | 0.39% | 1,616,802 | 60.44B |
| 6 | NVS | Novartis AG | 287.49B | 0.86% | 999,032 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 282.15B | 1.49% | 7,555,202 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 197.76B | - | 9,704,430 | 50.57B |
| 9 | AMGN | Amgen Inc. | 178.51B | 1.96% | 3,040,232 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 166.42B | 1.31% | 3,418,578 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 162.02B | 0.64% | 5,008,142 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 156.39B | 0.38% | 2,798,634 | 10.58B |
| 13 | ABT | Abbott Laboratories | 154.71B | 1.04% | 11,692,850 | 45.13B |
| 14 | PFE | Pfizer Inc. | 146.25B | 1.30% | 41,036,715 | 63.32B |
| 15 | SYK | Stryker Corporation | 121.81B | 1.45% | 3,575,732 | 25.27B |
| 16 | CVS | CVS Health Corporation | 120.17B | -1.89% | 12,935,471 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.07B | 1.74% | 7,998,310 | 48.48B |
| 18 | DHR | Danaher Corporation | 118.23B | 1.94% | 5,744,313 | 24.78B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.23B | -0.52% | 1,219,541 | 12.22B |
| 20 | SNY | Sanofi | 104.65B | 0.02% | 2,251,102 | 54.60B |
| 21 | GSK | GSK plc | 101.70B | 1.57% | 3,834,731 | 43.29B |
| 22 | MDT | Medtronic plc | 100.89B | 1.63% | 11,931,533 | 35.48B |
| 23 | MCK | McKesson Corporation | 91.58B | -1.81% | 1,264,562 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 89.78B | -4.28% | 2,695,812 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 87.36B | 2.08% | 1,607,564 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 84.44B | 1.59% | 22,605,178 | 20.61B |
| 27 | CI | The Cigna Group | 77.05B | 1.60% | 1,259,694 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.13B | 0.10% | 1,444,842 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.15B | 0.06% | 2,344,121 | 28.34B |
| 30 | COR | Cencora, Inc. | 51.79B | 1.64% | 1,813,034 | 328.68B |
| 31 | MDLN | Medline Inc. | 49.53B | 4.66% | 8,086,200 | 29.14B |
| 32 | ARGX | argenx SE | 49.39B | 2.77% | 290,926 | 4.74B |
| 33 | EW | Edwards Lifesciences Corporation | 47.31B | -0.28% | 4,086,798 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 46.93B | 0.30% | 2,803,857 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.11B | 0.13% | 719,662 | 4.45B |
| 36 | HLN | Haleon plc | 40.62B | 0.33% | 6,790,672 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.49B | 3.23% | 4,219,468 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 39.67B | 0.12% | 3,060,041 | 17.35B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.29B | 2.81% | 770,305 | 4.29B |
| 40 | HUM | Humana Inc. | 37.29B | 1.49% | 1,720,318 | 137.20B |
| 41 | ZTS | Zoetis Inc. | 33.09B | 1.54% | 7,296,777 | 9.53B |
| 42 | ONC | BeOne Medicines AG | 33.02B | 1.34% | 219,133 | 5.70B |
| 43 | WAT | Waters Corporation | 32.72B | 0.32% | 781,065 | 3.77B |
| 44 | ALC | Alcon Inc. | 32.60B | 0.47% | 3,522,482 | 10.63B |
| 45 | RVMD | Revolution Medicines, Inc. | 31.32B | 2.03% | 1,995,893 | - |
| 46 | A | Agilent Technologies, Inc. | 31.25B | -1.37% | 3,142,679 | 7.07B |
| 47 | RPRX | Royalty Pharma plc | 30.18B | 0.65% | 3,808,472 | 2.44B |
| 48 | RMD | ResMed Inc. | 30.14B | 1.78% | 1,410,823 | 5.54B |
| 49 | CNC | Centene Corporation | 29.21B | 1.58% | 4,449,548 | 178.33B |
| 50 | IQV | IQVIA Holdings Inc. | 28.90B | 0.21% | 1,645,384 | 16.63B |
| 51 | BIIB | Biogen Inc. | 28.13B | -0.70% | 1,054,123 | 9.94B |
| 52 | NTRA | Natera, Inc. | 28.08B | 1.82% | 1,273,692 | 2.50B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.01B | 0.11% | 5,312,181 | 20.98B |
| 54 | VEEV | Veeva Systems Inc. | 26.65B | -0.33% | 2,475,040 | 3.20B |
| 55 | DXCM | DexCom, Inc. | 25.83B | 2.86% | 11,300,837 | 4.82B |
| 56 | PHG | Koninklijke Philips N.V. | 24.91B | - | 952,158 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.06B | -0.03% | 403,912 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.28B | 0.24% | 3,647,485 | 819.56M |
| 59 | BNTX | BioNTech SE | 22.20B | -1.19% | 774,522 | 3.23B |
| 60 | WST | West Pharmaceutical Services, Inc. | 21.47B | -0.16% | 565,559 | 3.22B |
| 61 | ILMN | Illumina, Inc. | 21.44B | 0.12% | 1,537,442 | 4.39B |
| 62 | MTD | Mettler-Toledo International Inc. | 21.23B | -2.24% | 318,074 | 4.09B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.08B | 0.29% | 794,561 | 11.28B |
| 64 | STE | STERIS plc | 21.03B | 0.73% | 794,742 | 5.94B |
| 65 | LH | Labcorp Holdings Inc. | 20.80B | -0.74% | 528,575 | 14.14B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.19B | -1.19% | 4,132,238 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.10B | 0.43% | 1,166,639 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.83B | -2.00% | 14,097,030 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.14B | -4.97% | 5,457,554 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.65B | 1.10% | 2,918,330 | 8.41B |
| 71 | THC | Tenet Healthcare Corporation | 16.49B | -0.55% | 2,182,721 | 21.46B |
| 72 | GMAB | Genmab A/S | 15.79B | -2.62% | 4,339,280 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.52B | -1.81% | 1,386,317 | 3.10B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.90B | 3.44% | 1,268,544 | 4.44B |
| 75 | ASND | Ascendis Pharma A/S | 14.78B | 0.14% | 507,658 | 998.25M |
| 76 | RGC | Regencell Bioscience Holdings Limited | 13.35B | -2.84% | 97,464 | - |
| 77 | SNN | Smith & Nephew plc | 13.24B | 1.78% | 1,430,340 | 6.16B |
| 78 | GH | Guardant Health, Inc. | 13.02B | 2.64% | 1,492,400 | 1.08B |
| 79 | SOLV | Solventum Corporation | 12.94B | -1.84% | 1,350,126 | 8.26B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 12.93B | 1.04% | 2,420,249 | 579.96M |
| 81 | PEN | Penumbra, Inc. | 12.84B | - | 664,438 | 1.45B |
| 82 | DVA | DaVita Inc. | 12.49B | -2.46% | 800,510 | 13.84B |
| 83 | SMMT | Summit Therapeutics Inc. | 12.30B | -1.06% | 2,644,207 | - |
| 84 | EXEL | Exelixis, Inc. | 12.23B | -2.35% | 2,843,822 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 1.82% | 1,519,487 | 1.06B |
| 86 | MEDP | Medpace Holdings, Inc. | 11.99B | -0.18% | 294,442 | 2.68B |
| 87 | COO | The Cooper Companies, Inc. | 11.99B | 0.84% | 1,684,292 | 4.15B |
| 88 | FMS | Fresenius Medical Care AG | 11.94B | -0.54% | 539,621 | 22.32B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.80B | -1.99% | 258,876 | 1.13B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 11.66B | 0.96% | 2,200,737 | 13.65B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 11.66B | -0.32% | 510,240 | 708.24M |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.47B | -1.10% | 2,177,338 | 3.58B |
| 93 | ALGN | Align Technology, Inc. | 11.11B | -2.28% | 1,403,566 | 4.10B |
| 94 | GMED | Globus Medical, Inc. | 10.85B | 1.27% | 2,082,597 | 3.10B |
| 95 | PODD | Insulet Corporation | 10.71B | 1.39% | 1,390,869 | 2.90B |
| 96 | RVTY | Revvity, Inc. | 10.70B | 0.41% | 1,049,124 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.39B | -1.26% | 695,780 | 6.07B |
| 98 | CYTK | Cytokinetics, Incorporated | 10.38B | 1.69% | 2,399,086 | 105.82M |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.31B | -1.04% | 2,121,022 | 622.01M |
| 100 | ENSG | The Ensign Group, Inc. | 10.19B | -0.44% | 487,641 | 5.27B |
| 101 | UHS | Universal Health Services, Inc. | 10.08B | -1.67% | 809,699 | 17.76B |
| 102 | ELAN | Elanco Animal Health Incorporated | 9.89B | -0.65% | 7,919,928 | 4.89B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 9.63B | 0.28% | 2,598,637 | 3.24B |
| 104 | MOH | Molina Healthcare, Inc. | 9.60B | -0.27% | 853,368 | 43.10B |
| 105 | BAX | Baxter International Inc. | 9.47B | 3.04% | 5,663,145 | 11.32B |
| 106 | MASI | Masimo Corporation | 9.36B | - | 733,490 | 1.56B |
| 107 | ABVX | ABIVAX Société Anonyme | 8.97B | 0.16% | 1,102,971 | 5.37M |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.94B | 0.02% | 300,530 | 7.46M |
| 109 | ICLR | ICON Public Limited Company | 8.67B | -0.20% | 967,124 | 8.10B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.65B | 0.53% | 191,189 | 417.30M |
| 111 | HSIC | Henry Schein, Inc. | 8.31B | 0.32% | 1,486,150 | 13.38B |
| 112 | GKOS | Glaukos Corporation | 8.21B | -1.60% | 728,869 | 551.35M |
| 113 | TEM | Tempus AI, Inc. | 8.18B | 4.38% | 5,877,066 | 1.36B |
| 114 | HALO | Halozyme Therapeutics, Inc. | 8.15B | 1.91% | 2,004,304 | 1.51B |
| 115 | IBRX | ImmunityBio, Inc. | 8.13B | -3.00% | 17,956,277 | 140.98M |
| 116 | NUVL | Nuvalent, Inc. | 7.98B | 1.10% | 560,739 | - |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.52B | -0.27% | 678,068 | 2.59B |
| 118 | OSCR | Oscar Health, Inc. | 7.38B | -3.08% | 6,700,311 | 13.30B |
| 119 | CRL | Charles River Laboratories International, Inc. | 7.34B | 1.67% | 1,086,544 | 4.03B |
| 120 | ATR | AptarGroup, Inc. | 7.25B | -1.90% | 575,789 | 3.87B |
| 121 | HQY | HealthEquity, Inc. | 7.15B | 1.94% | 1,240,268 | 1.31B |
| 122 | TECH | Bio-Techne Corporation | 7.12B | 2.34% | 3,381,907 | 1.21B |
| 123 | QGEN | Qiagen N.V. | 7.08B | 1.36% | 2,596,288 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 7.04B | 0.70% | 1,065,762 | - |
| 125 | GRFS | Grifols, S.A. | 6.52B | -0.57% | 434,026 | 8.58B |
| 126 | BRKR | Bruker Corporation | 6.48B | -0.39% | 3,051,817 | 3.46B |
| 127 | KYMR | Kymera Therapeutics, Inc. | 6.43B | -1.92% | 587,743 | 51.48M |
| 128 | CELC | Celcuity Inc. | 6.39B | -0.92% | 640,861 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.33B | -2.35% | 492,707 | 74.06M |
| 130 | CORT | Corcept Therapeutics Incorporated | 6.25B | 5.62% | 1,498,390 | 769.10M |
| 131 | ALKS | Alkermes plc | 6.17B | -0.51% | 2,154,178 | 1.56B |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.15% | 787,624 | 15.00M |
| 133 | RGEN | Repligen Corporation | 6.12B | 4.15% | 2,221,242 | 763.34M |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.05B | -0.26% | 1,150,443 | 1.55B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.98B | 0.43% | 527,830 | 217.17M |
| 136 | TFX | Teleflex Incorporated | 5.88B | 1.79% | 744,227 | 2.13B |
| 137 | APGE | Apogee Therapeutics, Inc. | 5.87B | -0.61% | 976,486 | - |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 5.83B | 0.17% | 1,312,494 | 569.61M |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.83B | 0.19% | 725,212 | 827.11M |
| 140 | CHE | Chemed Corporation | 5.82B | -0.36% | 171,993 | 2.54B |
| 141 | PACS | PACS Group, Inc. | 5.81B | -0.24% | 951,414 | 5.43B |
| 142 | SYRE | Spyre Therapeutics, Inc. | 5.79B | -4.94% | 1,385,678 | - |
| 143 | BLCO | Bausch + Lomb Corporation | 5.78B | 0.56% | 290,751 | 5.21B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.70B | 0.38% | 873,602 | - |
| 145 | TGTX | TG Therapeutics, Inc. | 5.59B | -0.13% | 1,223,699 | 700.35M |
| 146 | CGON | CG Oncology, Inc. | 5.58B | 0.59% | 675,117 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.50B | -2.24% | 190,345 | - |
| 148 | IMVT | Immunovant, Inc. | 5.35B | -0.90% | 1,444,360 | - |
| 149 | COGT | Cogent Biosciences, Inc. | 5.34B | -0.35% | 2,819,207 | - |
| 150 | LQDA | Liquidia Corporation | 5.33B | 5.28% | 1,578,470 | 288.07M |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.22B | 0.63% | 852,789 | 7.50M |
| 152 | AVTR | Avantor, Inc. | 5.22B | 0.53% | 8,684,911 | 6.55B |
| 153 | HIMS | Hims & Hers Health, Inc. | 5.19B | 0.67% | 27,374,681 | 2.37B |
| 154 | LEGN | Legend Biotech Corporation | 5.00B | -0.15% | 1,154,406 | 1.14B |
| 155 | STVN | Stevanato Group S.p.A. | 4.73B | -2.59% | 295,873 | 1.39B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.68B | 2.48% | 531,837 | 1.34M |
| 157 | CRSP | CRISPR Therapeutics AG | 4.59B | -2.00% | 1,689,051 | 4.10M |
| 158 | SHC | Sotera Health Company | 4.34B | -0.78% | 2,696,451 | 1.19B |
| 159 | HNGE | Hinge Health, Inc. | 4.25B | 0.46% | 854,119 | 646.34M |
| 160 | CAI | Caris Life Sciences, Inc. | 4.23B | -0.93% | 2,460,715 | 907.29M |
| 161 | RDNT | RadNet, Inc. | 4.20B | -1.51% | 411,699 | 2.14B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | -0.05% | 198,728 | 274.48M |
| 163 | MANE | Veradermics, Incorporated | 4.12B | -0.31% | 289,837 | - |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.10B | -0.56% | 466,109 | 754.05M |
| 165 | LIVN | LivaNova PLC | 4.01B | 0.96% | 801,796 | 1.43B |
| 166 | TVTX | Travere Therapeutics, Inc. | 3.93B | -1.47% | 1,294,000 | 536.20M |
| 167 | NAMS | NewAmsterdam Pharma Company N.V. | 3.88B | -1.23% | 2,085,060 | 22.57M |
| 168 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | -0.06% | 2,976,937 | 596.96M |
| 169 | MMSI | Merit Medical Systems, Inc. | 3.80B | 0.20% | 523,611 | 1.54B |
| 170 | BLLN | BillionToOne, Inc. | 3.78B | -4.45% | 476,489 | 354.54M |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 3.77B | -0.92% | 1,387,080 | 3.05B |
| 172 | WAY | Waystar Holding Corp. | 3.76B | 5.66% | 3,071,672 | 1.16B |
| 173 | NVST | Envista Holdings Corporation | 3.75B | -0.43% | 6,587,893 | 2.81B |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.74B | 2.61% | 663,101 | 787.85M |
| 175 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.68B | 0.69% | 932,237 | 18.07M |
| 176 | DOCS | Doximity, Inc. | 3.56B | -1.63% | 5,788,938 | 644.86M |
| 177 | OGN | Organon & Co. | 3.52B | - | 2,502,948 | 6.16B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.51B | -1.01% | 2,089,299 | 1.10B |
| 179 | ORKA | Oruka Therapeutics, Inc. | 3.47B | -1.44% | 2,254,759 | - |
| 180 | TLX | Telix Pharmaceuticals Limited | 3.42B | -1.07% | 81,089 | 803.79M |
| 181 | ALHC | Alignment Healthcare, Inc. | 3.38B | 0.49% | 3,766,381 | 4.26B |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | -0.91% | 1,057,276 | - |
| 183 | VCYT | Veracyte, Inc. | 3.33B | 0.46% | 970,904 | 541.74M |
| 184 | VKTX | Viking Therapeutics, Inc. | 3.30B | -1.01% | 1,802,450 | - |
| 185 | OPCH | Option Care Health, Inc. | 3.28B | 5.94% | 6,666,195 | 5.67B |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 3.27B | -2.11% | 601,984 | 2.23B |
| 187 | ERAS | Erasca, Inc. | 3.21B | 0.49% | 4,020,589 | - |
| 188 | BKD | Brookdale Senior Living Inc. | 3.16B | -0.23% | 3,077,268 | 3.00B |
| 189 | WRBY | Warby Parker Inc. | 3.13B | -10.96% | 11,795,541 | 890.57M |
| 190 | ICUI | ICU Medical, Inc. | 3.09B | 0.47% | 234,235 | 2.16B |
| 191 | TWST | Twist Bioscience Corporation | 3.08B | -0.58% | 870,391 | 409.48M |
| 192 | ITGR | Integer Holdings Corporation | 3.07B | 0.52% | 406,640 | 1.86B |
| 193 | NHC | National HealthCare Corporation | 3.06B | -0.15% | 102,065 | 1.53B |
| 194 | MMED | MiniMed Group, Inc. | 3.06B | -0.05% | 634,841 | 2.99B |
| 195 | LFST | LifeStance Health Group, Inc. | 3.00B | -0.90% | 3,430,552 | 1.49B |
| 196 | TNGX | Tango Therapeutics, Inc. | 2.94B | -1.60% | 1,917,530 | 56.99M |
| 197 | PRVA | Privia Health Group, Inc. | 2.93B | -1.67% | 878,995 | 2.25B |
| 198 | DNLI | Denali Therapeutics Inc. | 2.87B | -1.58% | 2,130,798 | - |
| 199 | RCUS | Arcus Biosciences, Inc. | 2.86B | -2.78% | 754,549 | 236.00M |
| 200 | TXG | 10x Genomics, Inc. | 2.83B | 3.92% | 2,321,232 | 638.78M |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.76B | -1.47% | 591,522 | 776.83M |
| 202 | ALMS | Alumis Inc. | 2.74B | 1.77% | 1,335,577 | 8.40M |
| 203 | GMRS | GMR Solutions Inc. | 2.69B | -9.72% | 2,148,114 | 5.74B |
| 204 | HAE | Haemonetics Corporation | 2.64B | -0.75% | 605,896 | 1.33B |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -2.44% | 640,654 | 535.08M |
| 206 | DYN | Dyne Therapeutics, Inc. | 2.63B | -3.75% | 1,689,053 | - |
| 207 | BEAM | Beam Therapeutics Inc. | 2.62B | -1.79% | 1,488,012 | 164.01M |
| 208 | GRAL | GRAIL, Inc. | 2.62B | 0.46% | 553,135 | 156.12M |
| 209 | GPCR | Structure Therapeutics Inc. | 2.55B | -0.64% | 593,728 | - |
| 210 | KLRA | Kailera Therapeutics, Inc. | 2.54B | 0.36% | 347,813 | - |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | - | 597,788 | 225.27M |
| 212 | IRON | Disc Medicine, Inc. | 2.45B | -4.16% | 671,709 | - |
| 213 | ELVN | Enliven Therapeutics, Inc. | 2.45B | 1.36% | 636,113 | - |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.44B | -2.65% | 4,512,129 | 415.62M |
| 215 | VERA | Vera Therapeutics, Inc. | 2.39B | -3.20% | 1,285,033 | - |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -0.23% | 566,904 | 865.00K |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.32B | 0.50% | 160,109 | 256.28M |
| 218 | RLAY | Relay Therapeutics, Inc. | 2.31B | -0.25% | 17,854,358 | 10.68M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.30B | 1.28% | 403,977 | 1.46B |
| 220 | HTFL | HeartFlow, Inc. | 2.29B | 3.70% | 2,284,977 | 191.42M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.29B | -1.54% | 2,934,623 | 3.37B |
| 222 | TMDX | TransMedics Group, Inc. | 2.29B | -3.23% | 1,475,430 | 635.89M |
| 223 | NKTR | Nektar Therapeutics | 2.28B | -1.24% | 883,460 | 55.63M |
| 224 | AXGN | Axogen, Inc. | 2.27B | 1.76% | 1,308,082 | 238.11M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.23B | -2.23% | 3,876,459 | 885.72M |
| 226 | IMNM | Immunome, Inc. | 2.23B | -1.21% | 765,376 | 4.02M |
| 227 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | -7.19% | 2,121,072 | 670.00M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.20B | -0.34% | 860,055 | 1.09B |
| 229 | DFTX | Definium Therapeutics, Inc. | 2.18B | -2.25% | 1,680,924 | - |
| 230 | NBTX | Nanobiotix S.A. | 2.16B | -6.63% | 72,752 | 38.27M |
| 231 | KOD | Kodiak Sciences Inc. | 2.15B | -1.71% | 1,081,184 | - |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.15B | -1.33% | 703,156 | - |
| 233 | ADPT | Adaptive Biotechnologies Corporation | 2.07B | 1.97% | 1,247,000 | 295.41M |
| 234 | ZLAB | Zai Lab Limited | 2.06B | -2.60% | 626,580 | 453.28M |
| 235 | HCM | HUTCHMED (China) Limited | 2.05B | 0.59% | 42,197 | 548.51M |
| 236 | SEM | Select Medical Holdings Corporation | 2.05B | 0.18% | 887,552 | 5.52B |
| 237 | TYRA | Tyra Biosciences, Inc. | 2.01B | -5.27% | 1,110,135 | - |
| 238 | ADMA | ADMA Biologics, Inc. | 2.00B | 2.98% | 3,074,551 | 509.86M |
| 239 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -0.32% | 775,616 | 298.30M |
| 240 | OMCL | Omnicell, Inc. | 1.99B | 1.39% | 436,969 | 1.23B |
| 241 | BHC | Bausch Health Companies Inc. | 1.99B | -0.37% | 1,768,958 | 10.53B |
| 242 | NVCR | NovoCure Limited | 1.97B | -2.58% | 994,767 | 674.41M |
| 243 | XRAY | DENTSPLY SIRONA Inc. | 1.95B | -0.81% | 9,689,669 | 3.68B |
| 244 | ASTH | Astrana Health, Inc. | 1.95B | 0.82% | 313,940 | 3.53B |
| 245 | PGNY | Progyny, Inc. | 1.93B | 2.29% | 2,161,296 | 1.29B |
| 246 | ESTA | Establishment Labs Holdings Inc. | 1.93B | -0.12% | 345,510 | 229.58M |
| 247 | PHVS | Pharvaris N.V. | 1.89B | 0.28% | 301,434 | - |
| 248 | TRVI | Trevi Therapeutics, Inc. | 1.88B | -1.41% | 1,215,897 | - |
| 249 | MESO | Mesoblast Limited | 1.87B | -0.68% | 140,139 | 65.38M |
| 250 | STOK | Stoke Therapeutics, Inc. | 1.87B | 3.20% | 704,561 | 32.08M |
| 251 | MD | Pediatrix Medical Group, Inc. | 1.85B | 1.63% | 887,036 | 1.93B |
| 252 | CLOV | Clover Health Investments, Corp. | 1.84B | 3.24% | 7,226,057 | 2.21B |
| 253 | NEOG | Neogen Corporation | 1.82B | -2.45% | 2,924,019 | 870.56M |
| 254 | ZYME | Zymeworks Inc. | 1.78B | -0.12% | 615,320 | 81.26M |
| 255 | SGRY | Surgery Partners, Inc. | 1.77B | -1.65% | 1,758,971 | 3.34B |
| 256 | AAPG | Ascentage Pharma Group International | 1.77B | 2.32% | 6,559 | 82.08M |
| 257 | VRDN | Viridian Therapeutics, Inc. | 1.76B | -0.81% | 1,796,011 | 70.92M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 1.76B | 2.04% | 713,716 | 899.11M |
| 259 | VCEL | Vericel Corporation | 1.76B | -1.09% | 565,650 | 292.09M |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -0.30% | 177,421 | 1.20B |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -2.18% | 2,292,425 | 2.18B |
| 262 | OCUL | Ocular Therapeutix, Inc. | 1.75B | -4.65% | 2,959,641 | 52.04M |
| 263 | ANAB | AnaptysBio, Inc. | 1.74B | 1.75% | 414,250 | 232.39M |
| 264 | PLSE | Pulse Biosciences, Inc. | 1.73B | -2.58% | 438,401 | 751.00K |
| 265 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -0.26% | 929,951 | 217.17M |
| 266 | ANIP | ANI Pharmaceuticals, Inc. | 1.70B | 1.24% | 257,445 | 923.71M |
| 267 | SION | Sionna Therapeutics, Inc. | 1.70B | -3.98% | 313,512 | - |
| 268 | ADUS | Addus HomeCare Corporation | 1.69B | -0.05% | 201,172 | 1.45B |
| 269 | SNDA | Sonida Senior Living, Inc. | 1.69B | -2.00% | 833,257 | 367.34M |
| 270 | UFPT | UFP Technologies, Inc. | 1.68B | - | 165,105 | 608.85M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.91% | 5,520,815 | 66.09M |
| 272 | AVAH | Aveanna Healthcare Holdings Inc. | 1.66B | -0.91% | 1,359,476 | 2.52B |
| 273 | OCS | Oculis Holding AG | 1.65B | -0.39% | 290,490 | 1.40M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -1.70% | 638,198 | 66.05M |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.64B | -2.27% | 307,006 | 20.00M |
| 276 | STAA | STAAR Surgical Company | 1.62B | 0.90% | 812,221 | 290.38M |
| 277 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 3.51% | 303,425 | 1.30M |
| 278 | INVA | Innoviva, Inc. | 1.60B | -0.32% | 809,268 | 420.69M |
| 279 | GENB | Generate Biomedicines, Inc. | 1.58B | -4.53% | 687,588 | 30.30M |
| 280 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -1.74% | 1,060,380 | 71.78M |
| 281 | PVLA | Palvella Therapeutics, Inc. | 1.57B | 3.95% | 208,424 | - |
| 282 | CAPR | Capricor Therapeutics, Inc. | 1.56B | -3.93% | 1,103,182 | 11.13M |
| 283 | QURE | uniQure N.V. | 1.56B | -0.96% | 872,076 | 18.09M |
| 284 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 2.06% | 8,589,442 | 285.61M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.51B | -1.38% | 16,010,886 | 66.41M |
| 286 | GHRS | GH Research PLC | 1.51B | 1.20% | 372,890 | - |
| 287 | ARDX | Ardelyx, Inc. | 1.50B | -0.33% | 2,357,868 | 427.68M |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.49B | -4.86% | 2,308,475 | 7.47M |
| 289 | GLUE | Monte Rosa Therapeutics, Inc. | 1.49B | -2.39% | 640,384 | 42.95M |
| 290 | PGEN | Precigen, Inc. | 1.48B | 2.21% | 2,957,145 | 31.60M |
| 291 | ENOV | Enovis Corporation | 1.48B | 2.02% | 1,037,842 | 2.28B |
| 292 | NUVB | Nuvation Bio Inc. | 1.48B | 0.71% | 4,538,519 | 143.05M |
| 293 | PRCT | PROCEPT BioRobotics Corporation | 1.47B | -0.38% | 1,298,893 | 322.02M |
| 294 | IMCR | Immunocore Holdings plc | 1.47B | 1.97% | 308,056 | 412.81M |
| 295 | AGL | agilon health, inc. | 1.47B | 1.61% | 194,228 | 5.82B |
| 296 | PRGO | Perrigo Company plc | 1.47B | -0.66% | 2,530,638 | 4.18B |
| 297 | NVAX | Novavax, Inc. | 1.46B | -0.34% | 2,988,795 | 596.34M |
| 298 | AHG | Akso Health Group | 1.46B | -1.45% | 10,470 | 14.84M |
| 299 | ATRC | AtriCure, Inc. | 1.46B | 1.12% | 714,860 | 552.16M |
| 300 | ATAI | AtaiBeckley Inc. | 1.45B | -4.58% | 4,560,487 | 3.49M |
| 301 | DMRA | Damora Therapeutics, Inc. | 1.45B | -3.45% | 249,544 | - |
| 302 | MBX | MBX Biosciences, Inc. | 1.45B | -1.90% | 610,126 | - |
| 303 | VIR | Vir Biotechnology, Inc. | 1.44B | -2.74% | 1,867,040 | 65.50M |
| 304 | IMTX | Immatics N.V. | 1.43B | 0.75% | 668,582 | 43.00M |
| 305 | HCSG | Healthcare Services Group, Inc. | 1.43B | -3.53% | 727,678 | 1.85B |
| 306 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.04% | 8,048,372 | 114.48M |
| 307 | ALMR | Alamar Biosciences, Inc. | 1.42B | -1.56% | 140,233 | 87.16M |
| 308 | NNNN | Anbio Biotechnology | 1.42B | 14.88% | 15,724 | 8.65M |
| 309 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.42B | -0.93% | 1,134,416 | -665.00K |
| 310 | SLS | SELLAS Life Sciences Group, Inc. | 1.41B | 4.12% | 7,865,211 | - |
| 311 | ARDT | Ardent Health, Inc. | 1.40B | -3.35% | 434,222 | 6.43B |
| 312 | AHCO | AdaptHealth Corp. | 1.38B | -3.45% | 1,387,628 | 3.29B |
| 313 | URGN | UroGen Pharma Ltd. | 1.38B | -1.12% | 555,477 | 140.49M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.38B | -0.82% | 317,483 | 1.50B |
| 315 | CMPS | COMPASS Pathways plc | 1.36B | -4.64% | 4,135,291 | - |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.35B | -0.16% | 470,141 | 20.00M |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.32B | 3.86% | 429,827 | - |
| 318 | FTRE | Fortrea Holdings Inc. | 1.30B | 0.99% | 873,659 | 2.71B |
| 319 | ATEC | Alphatec Holdings, Inc. | 1.26B | 1.61% | 2,518,684 | 787.08M |
| 320 | BHVN | Biohaven Ltd. | 1.26B | -1.18% | 1,486,291 | - |
| 321 | WGS | GeneDx Holdings Corp. | 1.25B | -1.31% | 1,655,257 | 442.68M |
| 322 | ABCL | AbCellera Biologics Inc. | 1.24B | -2.64% | 4,600,609 | 79.21M |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.23B | 2.19% | 186,520 | - |
| 324 | INSP | Inspire Medical Systems, Inc. | 1.23B | 1.67% | 1,021,661 | 915.25M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.22B | -3.22% | 435,380 | - |
| 326 | PNTG | The Pennant Group, Inc. | 1.22B | -1.02% | 146,377 | 1.02B |
| 327 | SVRA | Savara Inc. | 1.20B | -3.87% | 1,080,988 | - |
| 328 | SEPN | Septerna, Inc. | 1.19B | 0.80% | 366,751 | 72.26M |
| 329 | TDOC | Teladoc Health, Inc. | 1.19B | 4.09% | 3,705,324 | 2.51B |
| 330 | MLTX | MoonLake Immunotherapeutics | 1.19B | -0.43% | 1,008,301 | - |
| 331 | WVE | Wave Life Sciences Ltd. | 1.18B | -4.06% | 8,084,951 | 71.80M |
| 332 | AVLN | Avalyn Pharma Inc. | 1.18B | 5.56% | 126,126 | - |
| 333 | AVNS | Avanos Medical, Inc. | 1.16B | 0.04% | 624,796 | 715.90M |
| 334 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | 1.07% | 275,871 | 83.72M |
| 335 | OLMA | Olema Pharmaceuticals, Inc. | 1.14B | 1.55% | 962,439 | - |
| 336 | HROW | Harrow, Inc. | 1.14B | -0.71% | 555,013 | 268.68M |
| 337 | ZBIO | Zenas BioPharma, Inc. | 1.13B | 5.50% | 659,030 | 10.00M |
| 338 | BLFS | BioLife Solutions, Inc. | 1.13B | 3.00% | 1,014,854 | 101.66M |
| 339 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -6.30% | 132,592 | - |
| 340 | IART | Integra LifeSciences Holdings Corporation | 1.12B | 1.91% | 968,279 | 1.64B |
| 341 | IRMD | IRADIMED CORPORATION | 1.12B | -1.29% | 198,596 | 86.28M |
| 342 | DBVT | DBV Technologies S.A. | 1.10B | -1.57% | 118,121 | 5.74M |
| 343 | AORT | Artivion, Inc. | 1.10B | -4.34% | 761,478 | 458.69M |
| 344 | NEO | NeoGenomics, Inc. | 1.09B | 0.24% | 1,206,814 | 745.97M |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -0.09% | 297,531 | 796.33M |
| 346 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.09B | 3.43% | 2,195,717 | 204.73M |
| 347 | CNMD | CONMED Corporation | 1.09B | -1.17% | 262,972 | 1.37B |
| 348 | JBIO | Jade Biosciences, Inc. | 1.08B | -0.59% | 931,478 | - |
| 349 | BFLY | Butterfly Network, Inc. | 1.07B | 6.77% | 5,482,750 | 102.92M |
| 350 | CDNA | CareDx, Inc. | 1.06B | -0.29% | 589,385 | 412.82M |
| 351 | AMN | AMN Healthcare Services, Inc. | 1.04B | -6.72% | 1,150,848 | 3.42B |
| 352 | ALVO | Alvotech | 1.03B | 0.92% | 277,555 | 562.04M |
| 353 | IVA | Inventiva S.A. | 1.02B | -2.19% | 273,776 | 7.94M |
| 354 | AKTS | Aktis Oncology, Inc. | 1.02B | -0.59% | 194,409 | 8.28M |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -1.50% | 1,395,369 | 314.85M |
| 356 | EYPT | EyePoint, Inc. | 991.00M | 1.03% | 736,322 | 7.61M |
| 357 | OMDA | Omada Health, Inc. | 986.85M | 0.79% | 850,700 | 283.30M |
| 358 | CRON | Cronos Group Inc. | 978.71M | -0.38% | 750,054 | 159.54M |
| 359 | INNV | InnovAge Holding Corp. | 978.66M | -0.55% | 242,323 | 949.17M |
| 360 | EVO | Evotec SE | 976.85M | 1.46% | 36,118 | 859.03M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 967.04M | -5.81% | 3,920,716 | - |
| 362 | TNDM | Tandem Diabetes Care, Inc. | 949.81M | 2.44% | 1,995,433 | 1.03B |
| 363 | LXRX | Lexicon Pharmaceuticals, Inc. | 945.94M | -0.47% | 1,646,458 | 69.64M |
| 364 | DRTS | Alpha Tau Medical Ltd. | 939.94M | 6.48% | 1,005,617 | - |
| 365 | USPH | U.S. Physical Therapy, Inc. | 937.63M | -5.27% | 218,721 | 787.69M |
| 366 | MNKD | MannKind Corporation | 914.49M | -1.00% | 4,549,094 | 360.78M |
| 367 | PHAT | Phathom Pharmaceuticals, Inc. | 905.50M | 0.09% | 1,010,950 | 204.89M |
| 368 | ETON | Eton Pharmaceuticals, Inc. | 900.93M | 1.23% | 467,782 | 86.93M |
| 369 | SDGR | Schrödinger, Inc. | 895.90M | -0.50% | 937,739 | 254.91M |
| 370 | PHAR | Pharming Group N.V. | 895.41M | -0.16% | 7,602 | 369.49M |
| 371 | BVS | Bioventus Inc. | 890.48M | 0.28% | 475,794 | 576.30M |
| 372 | INMD | InMode Ltd. | 885.12M | -0.92% | 760,699 | 374.64M |
| 373 | PCRX | Pacira BioSciences, Inc. | 877.85M | -0.58% | 440,989 | 734.86M |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 871.17M | -4.67% | 1,177,474 | - |
| 375 | TALK | Talkspace, Inc. | 871.07M | - | 968,350 | 238.37M |
| 376 | NUTX | Nutex Health Inc. | 869.73M | 1.36% | 87,208 | 879.95M |
| 377 | OPK | OPKO Health, Inc. | 868.36M | 1.77% | 2,457,895 | 581.12M |
| 378 | OMER | Omeros Corporation | 866.33M | 2.31% | 1,374,098 | 9.89M |
| 379 | GDRX | GoodRx Holdings, Inc. | 853.46M | 0.80% | 1,002,526 | 787.89M |
| 380 | SANA | Sana Biotechnology, Inc. | 851.57M | 0.66% | 3,385,719 | - |
| 381 | MGTX | MeiraGTx Holdings plc | 845.52M | -2.87% | 3,016,935 | 79.76M |
| 382 | JANX | Janux Therapeutics, Inc. | 842.19M | -1.57% | 3,532,001 | 13.73M |
| 383 | TBPH | Theravance Biopharma, Inc. | 837.74M | -0.06% | 313,848 | 109.78M |
| 384 | SPTX | Seaport Therapeutics, Inc. | 830.42M | -0.32% | 158,911 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 829.66M | 0.72% | 868,970 | 191.45M |
| 386 | ORIC | ORIC Pharmaceuticals, Inc. | 825.03M | 0.50% | 824,742 | - |
| 387 | AURA | Aura Biosciences, Inc. | 815.11M | -1.07% | 555,369 | - |
| 388 | AZTA | Azenta, Inc. | 813.54M | 8.68% | 1,795,246 | 596.48M |
| 389 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 6,963,818 | 418.24M |
| 390 | ANNX | Annexon, Inc. | 804.47M | -1.01% | 2,576,058 | - |
| 391 | SSII | SS Innovations International, Inc. | 799.76M | - | 38,016 | 48.47M |
| 392 | ODTX | Odyssey Therapeutics, Inc. | 799.13M | -2.59% | 376,526 | 2.98M |
| 393 | AVTX | Avalo Therapeutics, Inc. | 798.15M | 0.68% | 1,670,960 | 59.00K |
| 394 | KURA | Kura Oncology, Inc. | 795.42M | -2.61% | 1,402,192 | 71.64M |
| 395 | CTMX | CytomX Therapeutics, Inc. | 792.44M | 4.00% | 6,760,231 | 35.54M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 785.74M | 3.60% | 725,146 | 720.53M |
| 397 | GERN | Geron Corporation | 782.66M | -0.81% | 10,550,464 | 196.12M |
| 398 | LBRX | LB Pharmaceuticals Inc | 782.01M | -1.69% | 164,554 | - |
| 399 | QDEL | QuidelOrtho Corporation | 776.01M | 4.98% | 2,249,542 | 2.66B |
| 400 | XNCR | Xencor, Inc. | 771.81M | -5.88% | 793,569 | 97.36M |
| 401 | VOR | Vor Biopharma Inc. | 765.64M | -0.14% | 714,217 | - |
| 402 | EVMN | Evommune, Inc. | 760.71M | -3.52% | 383,521 | 10.00M |
| 403 | DRUG | Bright Minds Biosciences Inc. | 737.61M | -0.61% | 235,565 | - |
| 404 | RLMD | Relmada Therapeutics, Inc. | 737.36M | 10.88% | 1,459,156 | - |
| 405 | PSNL | Personalis, Inc. | 737.24M | 4.76% | 1,868,316 | 64.52M |
| 406 | BIOA | BioAge Labs, Inc. | 727.69M | 6.71% | 520,430 | 10.32M |
| 407 | ABSI | Absci Corporation | 721.84M | -6.37% | 4,596,182 | 1.84M |
| 408 | AVR | Anteris Technologies Global Corp. | 717.48M | 1.72% | 1,648,220 | 1.85M |
| 409 | ANRO | Alto Neuroscience, Inc. | 716.83M | -6.19% | 330,310 | - |
| 410 | CERT | Certara, Inc. | 714.04M | 0.66% | 2,918,618 | 419.75M |
| 411 | HSTM | HealthStream, Inc. | 713.73M | 2.74% | 371,547 | 311.78M |
| 412 | SPRY | ARS Pharmaceuticals, Inc. | 712.00M | -1.78% | 1,604,310 | 98.99M |
| 413 | SGP | SpyGlass Pharma, Inc. | 708.64M | -4.68% | 45,165 | - |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 697.89M | -0.34% | 629,645 | - |
| 415 | TENX | Tenax Therapeutics, Inc. | 675.63M | -1.25% | 356,508 | - |
| 416 | LMRI | Lumexa Imaging Holdings, Inc. | 672.57M | 3.40% | 3,115,161 | 1.03B |
| 417 | SIBN | SI-BONE, Inc. | 658.14M | 0.54% | 582,395 | 206.22M |
| 418 | DSGN | Design Therapeutics, Inc. | 655.17M | -1.96% | 2,165,370 | - |
| 419 | ALLO | Allogene Therapeutics, Inc. | 652.34M | -2.58% | 7,155,208 | 22.00K |
| 420 | CBLL | CeriBell, Inc. | 643.51M | 2.29% | 301,743 | 95.07M |
| 421 | ACRS | Aclaris Therapeutics, Inc. | 621.50M | 1.14% | 1,196,465 | 8.37M |
| 422 | TLRY | Tilray Brands, Inc. | 621.46M | 0.58% | 2,129,029 | 858.28M |
| 423 | CBIO | Crescent Biopharma, Inc. | 614.07M | -0.38% | 127,955 | 11.88M |
| 424 | CRMD | CorMedix Inc. | 613.49M | -1.14% | 1,737,225 | 400.05M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 604.13M | 4.86% | 3,435,172 | 361.51M |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 602.97M | -2.21% | 2,541,566 | 122.29M |
| 427 | BWAY | BrainsWay Ltd. | 600.41M | 0.07% | 223,593 | 56.22M |
| 428 | SLDB | Solid Biosciences Inc. | 598.57M | -6.61% | 1,831,830 | - |
| 429 | CSTL | Castle Biosciences, Inc. | 582.34M | -0.62% | 343,466 | 339.92M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 581.31M | -6.35% | 508,975 | - |
| 431 | EIKN | Eikon Therapeutics, Inc. | 576.03M | -9.45% | 428,111 | - |
| 432 | GYRE | Gyre Therapeutics, Inc. | 571.99M | -2.80% | 92,693 | 117.05M |
| 433 | CADL | Candel Therapeutics, Inc. | 561.25M | -3.04% | 1,944,371 | - |
| 434 | PHR | Phreesia, Inc. | 557.20M | 0.99% | 1,453,576 | 480.59M |
| 435 | ARVN | Arvinas, Inc. | 551.66M | -2.62% | 1,480,152 | 89.40M |
| 436 | TCMD | Tactile Systems Technology, Inc. | 547.21M | 2.58% | 265,103 | 343.52M |
| 437 | MDXG | MiMedx Group, Inc. | 542.16M | 1.39% | 1,228,812 | 389.42M |
| 438 | CERS | Cerus Corporation | 541.00M | 11.11% | 4,450,620 | 216.56M |
| 439 | NPCE | NeuroPace, Inc. | 540.39M | -0.88% | 111,398 | 99.53M |
| 440 | VALN | Valneva SE | 537.83M | 0.70% | 45,717 | 180.25M |
| 441 | CABA | Cabaletta Bio, Inc. | 533.17M | -0.61% | 2,753,654 | - |
| 442 | ALT | Altimmune, Inc. | 532.86M | -2.14% | 2,512,579 | 36.00K |
| 443 | KYTX | Kyverna Therapeutics, Inc. | 526.61M | 1.87% | 1,038,664 | - |
| 444 | STRO | Sutro Biopharma, Inc. | 524.70M | -8.15% | 729,422 | 99.61M |
| 445 | RIGL | Rigel Pharmaceuticals, Inc. | 523.61M | -1.08% | 386,852 | 299.77M |
| 446 | XOMA | XOMA Royalty Corporation | 520.95M | -0.22% | 121,743 | 48.56M |
| 447 | AGMB | AgomAb Therapeutics NV | 517.60M | -0.47% | 29,563 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 514.94M | -1.48% | 215,831 | - |
| 449 | AQST | Aquestive Therapeutics, Inc. | 513.09M | -1.09% | 1,557,571 | 50.27M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 451 | FBRX | Forte Biosciences, Inc. | 490.42M | -4.29% | 323,706 | - |
| 452 | OFIX | Orthofix Medical Inc. | 488.70M | -0.41% | 218,694 | 825.37M |
| 453 | PRME | Prime Medicine, Inc. | 487.67M | -3.91% | 2,235,210 | 4.03M |
| 454 | DNA | Ginkgo Bioworks Holdings, Inc. | 480.79M | -0.14% | 825,354 | 151.40M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 477.05M | -0.78% | 111,978 | - |
| 456 | ANGO | AngioDynamics, Inc. | 476.84M | 3.34% | 360,162 | 313.73M |
| 457 | PRTA | Prothena Corporation plc | 474.84M | -5.42% | 627,299 | 57.94M |
| 458 | IMMX | Immix Biopharma, Inc. | 469.69M | -1.45% | 1,052,636 | - |
| 459 | KIDS | OrthoPediatrics Corp. | 468.24M | 0.50% | 96,234 | 243.30M |
| 460 | PROK | ProKidney Corp. | 468.04M | -3.73% | 891,568 | 889.00K |
| 461 | WEAV | Weave Communications, Inc. | 461.48M | 6.62% | 1,473,325 | 248.72M |
| 462 | CTKB | Cytek Biosciences, Inc. | 461.04M | 0.56% | 968,448 | 204.17M |
| 463 | CLYM | Climb Bio, Inc. | 460.97M | -2.33% | 516,038 | - |
| 464 | ACHV | Achieve Life Sciences, Inc. | 456.83M | -6.71% | 1,309,298 | - |
| 465 | FLGT | Fulgent Genetics, Inc. | 452.99M | 0.63% | 410,423 | 320.35M |
| 466 | VTVT | vTv Therapeutics Inc. | 452.82M | 2.82% | 65,400 | 36.84M |
| 467 | SRTA | Strata Critical Medical, Inc. | 451.67M | -2.79% | 943,857 | 228.58M |
| 468 | KMDA | Kamada Ltd. | 445.10M | -2.81% | 54,817 | 181.68M |
| 469 | OCGN | Ocugen, Inc. | 440.08M | -2.99% | 5,555,124 | 4.47M |
| 470 | FDMT | 4D Molecular Therapeutics, Inc. | 439.38M | 0.42% | 873,727 | 88.24M |
| 471 | STTK | Shattuck Labs, Inc. | 437.62M | -3.02% | 625,036 | 1.00M |
| 472 | EVH | Evolent Health, Inc. | 437.55M | -0.26% | 2,046,572 | 1.89B |
| 473 | UPB | Upstream Bio, Inc. | 436.99M | -5.64% | 853,221 | 3.32M |
| 474 | AUTL | Autolus Therapeutics plc | 433.81M | -9.44% | 1,709,442 | 92.62M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 429.47M | -1.61% | 404,328 | 16.72M |
| 476 | ANL | Adlai Nortye Ltd. | 428.00M | -7.84% | 354,060 | 5.00M |
| 477 | NGNE | Neurogene Inc. | 424.76M | -3.93% | 150,058 | 925.00K |
| 478 | EOLS | Evolus, Inc. | 423.45M | -2.13% | 660,750 | 301.79M |
| 479 | PRTC | PureTech Health plc | 423.21M | 2.09% | 21,280 | 4.66M |
| 480 | NRC | NRC Health | 422.56M | 0.05% | 99,625 | 138.64M |
| 481 | ASMB | Assembly Biosciences, Inc. | 421.47M | -3.28% | 116,170 | 71.10M |
| 482 | BBNX | Beta Bionics, Inc. | 419.77M | 0.21% | 584,112 | 110.24M |
| 483 | EBS | Emergent BioSolutions Inc. | 415.87M | -0.86% | 671,966 | 676.80M |
| 484 | ARTV | Artiva Biotherapeutics, Inc. | 415.43M | -7.27% | 844,926 | 251.00K |
| 485 | OVID | Ovid Therapeutics Inc. | 415.29M | -0.41% | 1,590,113 | 7.12M |
| 486 | CATX | Perspective Therapeutics, Inc. | 413.99M | -3.46% | 882,060 | 618.00K |
| 487 | MOBI | Mobia Medical, Inc. | 412.24M | 0.73% | 58,405 | 32.04M |
| 488 | TOI | The Oncology Institute, Inc. | 409.93M | 2.50% | 2,132,564 | 545.76M |
| 489 | CCRN | Cross Country Healthcare, Inc. | 406.21M | - | 646,531 | 1.00B |
| 490 | SGMT | Sagimet Biosciences Inc. | 403.86M | -1.80% | 938,896 | - |
| 491 | ENTA | Enanta Pharmaceuticals, Inc. | 400.12M | 2.30% | 203,871 | 69.21M |
| 492 | ADCT | ADC Therapeutics SA | 399.38M | -0.95% | 885,284 | 79.18M |
| 493 | FULC | Fulcrum Therapeutics, Inc. | 393.80M | -2.96% | 492,190 | 80.00M |
| 494 | VREX | Varex Imaging Corporation | 392.81M | -3.92% | 359,569 | 857.50M |
| 495 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.44M | -5.98% | 485,308 | - |
| 496 | LAB | Standard BioTools Inc. | 390.37M | 1.10% | 1,167,370 | 86.26M |
| 497 | REPL | Replimune Group, Inc. | 388.09M | -6.19% | 4,541,481 | - |
| 498 | TBRG | TruBridge, Inc. | 383.91M | - | 179,889 | 345.90M |
| 499 | IPSC | Century Therapeutics, Inc. | 382.35M | -6.36% | 930,584 | 109.16M |
| 500 | CYH | Community Health Systems, Inc. | 379.27M | - | 1,706,720 | 12.29B |